Related references
Note: Only part of the references are listed.CIP2A is overexpressed in esophageal squamous cell carcinoma
Wei Qu et al.
MEDICAL ONCOLOGY (2012)
Oncologic Resection for Malignant Tumors of the Liver
Shefali Agrawal et al.
ANNALS OF SURGERY (2011)
Hepatocellular Carcinoma Current Management and Perspectives for the Future
Nuh N. Rahbari et al.
ANNALS OF SURGERY (2011)
CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
Qian-Ze Dong et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression
Claire M. Lucas et al.
BLOOD (2011)
High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer
C. Bockelman et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein
Juan Liu et al.
GYNECOLOGIC ONCOLOGY (2011)
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue
Hua-Xiang Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation
J. Wang et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2011)
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
Jiliang Qiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect
I. Cristobal et al.
LEUKEMIA (2011)
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
Augusto Villanueva et al.
ANNUAL REVIEW OF MEDICINE (2010)
CIP2A expression and localization in oral carcinoma and dysplasia
Joseph Katz et al.
CANCER BIOLOGY & THERAPY (2010)
New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers
Augusto Villanueva et al.
CLINICAL CANCER RESEARCH (2010)
CIP2A increases self-renewal and is linked to Myc in neural progenitor cells
Laura Kerosuo et al.
DIFFERENTIATION (2010)
CIP2A expression is increased in prostate cancer
Markku H. Vaarala et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
Kuen-Feng Chen et al.
JOURNAL OF HEPATOLOGY (2010)
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
K-F Chen et al.
ONCOGENE (2010)
CIP2A Is Associated with Human Breast Cancer Aggressivity
Christophe Come et al.
CLINICAL CANCER RESEARCH (2009)
MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
Anchit Khanna et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Major achievements in hepato cellular carcinoma
Jordi Bruix et al.
LANCET (2009)
CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells
Wenjuan Li et al.
CLINICAL CANCER RESEARCH (2008)
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis
M. A. Silva et al.
GUT (2008)
Molecular Mechanisms of Hepatocellular Carcinoma
Rajagopal N. Aravalli et al.
HEPATOLOGY (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CIP2A inhibits PP2A in human malignancies
Melissa R. Junttila et al.
CELL (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas
O Morimoto et al.
JOURNAL OF HEPATOLOGY (2003)
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis
L Libbrecht et al.
HISTOPATHOLOGY (2001)
Share Paper
